PHENOBARBITAL SODIUM MOLECULAR WEIGHT - AN OVERVIEW

pentobarbital will minimize the extent or effect of naloxegol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Utilization of naloxegol with potent CYP3A4 inducers will not be advisablepentobarbital will reduce the level or effect of alosetron by influencing hepatic enzyme CYP2C9/10 metabolism. Small/Importance Unknown.Non